[Market Focus] PeopleBio Hits Upper Price Limit on "Unqualified" Audit Opinion
PeopleBio, a company specializing in blood-based Alzheimer’s diagnostics, hit the upper price limit early in trading after receiving an "unqualified" opinion on its audit report.
As of 9:47 a.m. on April 9, PeopleBio was trading at 1,271 won, up 29.96% (293 won) from the previous session.
On April 7, PeopleBio received an "unqualified" audit opinion from its external auditor for its previous fiscal year report. This outcome appears to have alleviated financial risks, boosting investor sentiment.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Additionally, the company acquired certification for meeting the requirements for venture status, and as a result, was reclassified from an investment warning category to the venture business sector as of the previous day.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.